{
    "clinical_study": {
        "@rank": "6365", 
        "arm_group": [
            {
                "arm_group_label": "Tenofovir DF", 
                "arm_group_type": "Experimental", 
                "description": "Participants will receive tenofovir disoproxil fumarate  (tenofovir DF; TDF) for 72 weeks during the blinded randomized treatment, and will switch to open-label TDF treatment for an additional 120 weeks."
            }, 
            {
                "arm_group_label": "Placebo to match TDF", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Participants will receive placebo to match TDF for 72 weeks during the blinded randomized treatment, and will switch to open-label TDF treatment for an additional 120 weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "This placebo-controlled study evaluates the efficacy, safety and tolerability of tenofovir\n      disoproxil fumarate (TDF) in participants 2 to < 12 years old with chronic Hepatitis B\n      infection.  While studies have shown significant virologic response in adults and\n      adolescents, the effect in children is not well established.  This study will provide\n      valuable data that can help establish the efficacy and safety profiles of TDF in children.\n      The study will consist of 72 weeks of blinded randomized treatment, after which participants\n      will switch to open-label TDF treatment for an additional 120 weeks."
        }, 
        "brief_title": "Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection", 
        "completion_date": {
            "#text": "March 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Hepatitis B Infection", 
        "condition_browse": {
            "mesh_term": [
                "Hepatitis", 
                "Hepatitis A", 
                "Hepatitis B", 
                "Hepatitis, Chronic", 
                "Hepatitis B, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or Female, 2 to < 12 years of age\n\n          -  Weight \u2265 10kg\n\n          -  Chronic HBV infection \u2265 6 months\n\n          -  HBeAg-positive or HBeAg-negative\n\n          -  HBV Viral Load \u2265 100,000 copies/mL\n\n          -  Alanin aminotransferase (ALT) \u2265 1.5 x the upper limit of the normal range (ULN) at\n             screening\n\n          -  Creatinine Clearance \u2265 80 mL/min\n\n          -  Absolute neutrophil count (ANC) \u2265 1,500/mm^3, hemoglobin \u2265 10g/dL\n\n          -  Negative pregnancy test at screening\n\n          -  No prior tenofovir DF therapy (subjects may have received prior interferon\u2011alfa\n             and/or other oral anti\u2011HBV nucleoside/nucleotide therapy; subjects must have\n             discontinued interferon-alfa therapy \u2265 6 months prior to screening; subjects\n             experienced on other anti-HBV nucleoside/nucleotide therapy must have discontinued\n             therapy \u2265 16 weeks prior to screening to avoid flare if randomized to the placebo\n             arm)\n\n        Exclusion Criteria:\n\n          -  Pregnant or lactating\n\n          -  Decompensated liver disease\n\n          -  Received interferon therapy within 6 months of Screening\n\n          -  Received anti-HBV nucleoside/nucleotide therapy within 16 weeks of Screening\n\n          -  Alpha-fetoprotein levels > 50 ng/mL\n\n          -  Evidence of hepatocellular carcinoma (HCC)\n\n          -  Co-infection with HIV, acute hepatitis A virus (HAV), hepatitis C virus (HCV), or\n             hepatitis D virus (HDV)\n\n          -  Chronic liver disease not due to HBV\n\n          -  History of significant renal, cardiovascular, pulmonary, neurological or bone disease\n\n          -  Long term non-steroidal, anti-inflammatory drug therapy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "11 Years", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01651403", 
            "org_study_id": "GS-US-174-0144", 
            "secondary_id": "2012-000586-20"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Tenofovir DF", 
                    "Placebo to match TDF"
                ], 
                "description": "Participants \u2265 17 kg will receive TDF one tablet administered orally once daily (150, 200, 250 or 300 mg tablets based on body weight).\nParticipants < 17 kg and participants \u2265 17 kg who are unable to swallow a tablet will receive oral powder containing 40 mg of TDF once daily.", 
                "intervention_name": "Tenofovir DF", 
                "intervention_type": "Drug", 
                "other_name": "Viread\u00ae"
            }, 
            {
                "arm_group_label": "Placebo to match TDF", 
                "description": "Matching placebo oral tablet / oral powder\nParticipants \u2265 17 kg will receive one tablet of placebo to match TDF administered orally once daily\nParticipants < 17 kg and participants \u2265 17 kg who are unable to swallow a tablet will receive placebo to match TDF oral powder once daily", 
                "intervention_name": "Placebo to match TDF", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Tenofovir", 
                "Tenofovir disoproxil"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Hepatitis", 
            "Hepatitis B", 
            "HBV"
        ], 
        "lastchanged_date": "May 7, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85016"
                    }, 
                    "name": "Phoenix Children's Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94143"
                    }, 
                    "name": "University of California, San Francisco"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "New York School of Medicine"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Texas Children's Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pleven", 
                        "country": "Bulgaria", 
                        "zip": "5800"
                    }, 
                    "name": "Dr. Georgi Stranski Multiprofile Hospital for Active Treatment"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Plodiv", 
                        "country": "Bulgaria", 
                        "zip": "4002"
                    }, 
                    "name": "University Multiprofile Hospital for Active Treatment \"Sveti Georgi\""
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sofia", 
                        "country": "Bulgaria", 
                        "zip": "1407"
                    }, 
                    "name": "Multiprofile Hospital for Active Treatment \"Tokuda Hospital\""
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Secunderabad", 
                        "country": "India", 
                        "state": "Andhra Pradesh", 
                        "zip": "500-033"
                    }, 
                    "name": "Gandhi Hospital and Medical College"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Visakhapatnam", 
                        "country": "India", 
                        "state": "Andhra Prasad", 
                        "zip": "530 002"
                    }, 
                    "name": "King George Hospital"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gujarat", 
                        "country": "India", 
                        "zip": "395 002"
                    }, 
                    "name": "Nirmal Hospital Private Limited"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Daegu", 
                        "country": "Korea, Republic of", 
                        "zip": "700-721"
                    }, 
                    "name": "Kyungpook National University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Incheon", 
                        "country": "Korea, Republic of", 
                        "zip": "405-760"
                    }, 
                    "name": "Gachon University Gil Hospital, Department of Pediatrics"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "120-752"
                    }, 
                    "name": "Severance Children's Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "138-736"
                    }, 
                    "name": "Asan Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "135-710"
                    }, 
                    "name": "Samsung Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yangsan-si", 
                        "country": "Korea, Republic of", 
                        "zip": "626 770"
                    }, 
                    "name": "Pusan National University Yangsan Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Myslowice", 
                        "country": "Poland", 
                        "zip": "41-400"
                    }, 
                    "name": "ID Clinic"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucharest", 
                        "country": "Romania", 
                        "zip": "021105"
                    }, 
                    "name": "National Institute of Infectious Diseases"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucharest", 
                        "country": "Romania", 
                        "zip": "022328"
                    }, 
                    "name": "Fundeni Clinical Institute - Constantinesco"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucharest", 
                        "country": "Romania", 
                        "zip": "011743"
                    }, 
                    "name": "Grigore Alexandrescu Emergency Clinical Hospital for Children"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Constanta", 
                        "country": "Romania", 
                        "zip": "900708"
                    }, 
                    "name": "Clinical Infectious Diseases Hospital of Constanta"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Craiova", 
                        "country": "Romania", 
                        "zip": "200515"
                    }, 
                    "name": "\"Victor Babes\" Clinical Hospital of Infectious Diseases and Pneumophtisology"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taipei", 
                        "country": "Taiwan", 
                        "zip": "11217"
                    }, 
                    "name": "Taipei Veterans General Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taipei", 
                        "country": "Taiwan", 
                        "zip": "100"
                    }, 
                    "name": "National Taiwan University Hospital"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Bulgaria", 
                "India", 
                "Korea, Republic of", 
                "Poland", 
                "Romania", 
                "Taiwan"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Patients With Chronic Hepatitis B Infection", 
        "overall_contact": {
            "email": "yvonne.walker@gilead.com", 
            "last_name": "Yvonne Walker"
        }, 
        "overall_official": {
            "affiliation": "Gilead Sciences", 
            "last_name": "Bittoo Kanwar, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Bulgaria: Bulgarian Drug Agency", 
                "India: Drugs Controller General of India", 
                "Poland: The Central Register of Clinical Trials", 
                "Romania: National Agency for Medicines and Medical Devices", 
                "South Korea: Korea Food and Drug Administration (KFDA)", 
                "Taiwan : Food and Drug Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Proportion of participants with serum HBV DNA < 400 copies/mL at week 72", 
            "safety_issue": "No", 
            "time_frame": "Week 72"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01651403"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Proportion of participants with hepatitis B e antigen (HBeAg) seroconversion at Week 72", 
                "safety_issue": "No", 
                "time_frame": "Week 72"
            }, 
            {
                "measure": "Cumulative Incidence of at least 4% decrease from baseline in bone mineral density of lumbar spine", 
                "safety_issue": "Yes", 
                "time_frame": "Week 72"
            }, 
            {
                "measure": "Percent change from baseline in bone mineral density of lumbar spine", 
                "safety_issue": "Yes", 
                "time_frame": "Week 72"
            }, 
            {
                "measure": "Proportion of participants with normal ALT and normalization of ALT", 
                "safety_issue": "No", 
                "time_frame": "Week 72"
            }, 
            {
                "measure": "Composite endpoint of proportion of participants with HBV DNA < 400 copies/mL and normal ALT", 
                "safety_issue": "No", 
                "time_frame": "Week 72"
            }, 
            {
                "measure": "Genotypic changes from baseline within the HBV polymerase for patients who were viremic (HBV DNA > or equal 400 copies/mL) with confirmed virologic breakthrough", 
                "safety_issue": "No", 
                "time_frame": "Weeks 72, 144, 192 or Early Discontinuation"
            }, 
            {
                "measure": "Proportion of participants with HBV DNA < 169 copies/mL", 
                "safety_issue": "No", 
                "time_frame": "Week 72"
            }, 
            {
                "measure": "Proportion of participants with HBsAg loss and seroconversion", 
                "safety_issue": "No", 
                "time_frame": "Week 72"
            }
        ], 
        "source": "Gilead Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gilead Sciences", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}